Pfizer Inc. (PFE) Looks For Other Acquisition Targets After Teva Pharmaceutical (TEVA) Rejection

Pfizer Inc. (NYSE:PFE) is looking to acquire companies to contribute to its revenue growth, and the hunt has become rather aggressive after Israel-based Teva Pharmaceutical Industries Ltd (NYSE:TEVA) rejected the company's acquisition offer, as per sources familiar with the matter. The financial details of the offer remain undisclosed.